Abstract

Gamma-Hydroxybutyric acid (GHB) is a short-chain fatty acid, an endogenous metabolite of the gamma-aminobutyric acid (GABA), a known major neurotransmitter inhibitor. GHB acts mainly on the CNS, with an enhanced affinity for receptors that are located in the cerebral cortex and the medulla oblongata.